Effect of Pycnogenol® on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial

BACKGROUND: Methylphenidate (MPH), the first choice medication for attention-deficit hyperactivity disorder (ADHD), is associated with serious adverse effects like arrhythmia. Evidence on the association of ADHD with immune and oxidant-antioxidant imbalances offers potential for antioxidant and/or i...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Trials
Prif Awduron: Verlaet, Annelies A. J., Ceulemans, Berten, Verhelst, Helene, Van West, Dirk, De Bruyne, Tess, Pieters, Luc, Savelkoul, Huub F. J., Hermans, Nina
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2017
Pynciau:
Study Protocol
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5370458/
https://ncbi.nlm.nih.gov/pubmed/28351412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-1879-6
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg